SG/CALL/QIAGEN/43.04/0.0999/20.12.24 Share Price

Warrant

DE000SQ8JDT7

Delayed Deutsche Boerse AG 12:32:09 01/07/2024 BST
0.15 EUR 0.00% Intraday chart for SG/CALL/QIAGEN/43.04/0.0999/20.12.24
Current month-34.78%
1 month-34.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/07/24 0.15 0.00%
28/06/24 0.15 -6.25%
27/06/24 0.16 +6.67%
26/06/24 0.15 -6.25%
25/06/24 0.16 -15.79%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 12:32 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying QIAGEN N.V.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ8JDT
ISINDE000SQ8JDT7
Date issued 01/02/2023
Strike 43.04
Maturity 20/12/2024 (172 Days)
Parity 10.01 : 1
Emission price 1.06
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.22
Lowest since issue 0.15
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 0.8822
Difference Strike 5.08
Difference Strike %+11.80%
Intrinsic value 0.000000

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
41.09 USD
Average target price
50.37 USD
Spread / Average Target
+22.57%
Consensus